Search hospitals > Pennsylvania > Pittsburgh

Allegheny General Hospital

Claim this profile
Pittsburgh, Pennsylvania 15212
Global Leader in Cancer
Global Leader in High Blood Pressure
Conducts research for Breast Cancer
Conducts research for Pulmonary Hypertension
Conducts research for Pulmonary Arterial Hypertension
473 reported clinical trials
61 medical researchers
Photo of Allegheny General Hospital in PittsburghPhoto of Allegheny General Hospital in Pittsburgh

Summary

Allegheny General Hospital is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Cancer, High Blood Pressure, Breast Cancer, Pulmonary Hypertension, Pulmonary Arterial Hypertension and other specialties. Allegheny General Hospital is involved with conducting 473 clinical trials across 640 conditions. There are 61 research doctors associated with this hospital, such as Thomas Krivak, Gene G. Finley, Dulabh Monga, MD, and Nathan Bahary, MD, PhD.

Area of expertise

1Cancer
Global Leader
Allegheny General Hospital has run 59 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
p16 positive
2High Blood Pressure
Global Leader
Allegheny General Hospital has run 57 trials for High Blood Pressure.

Top PIs

Clinical Trials running at Allegheny General Hospital

Breast Cancer
Squamous Cell Carcinoma
Cancer
Bladder Carcinoma
Non-Small Cell Lung Cancer
Bladder Cancer
Colorectal Cancer
Prostate Cancer
Heart Failure
Lung Cancer
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Allegheny General Hospital?
Allegheny General Hospital is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Cancer, High Blood Pressure, Breast Cancer, Pulmonary Hypertension, Pulmonary Arterial Hypertension and other specialties. Allegheny General Hospital is involved with conducting 473 clinical trials across 640 conditions. There are 61 research doctors associated with this hospital, such as Thomas Krivak, Gene G. Finley, Dulabh Monga, MD, and Nathan Bahary, MD, PhD.
Where is Allegheny General Hospital located?
**Directions to Allegheny General Hospital, Pittsburgh, Pennsylvania:** - From the North: Take I-79 South to I-279 South, then I-279 North to East Street Exit (Exit 2B). Turn right onto North Avenue, then right onto James Street, and left into the parking garage. - From the West/Pittsburgh International Airport: Take I-79 South to I-376, then I-279 North across the Fort Pitt Bridge. Take the East Ohio Street Exit (Exit 1D), turn left onto East Ohio Street, then right onto James Street, and left into the parking garage.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Allegheny General Hospital, contact AHN Patient Financial Services at 1-833-684-0239. For details on the Financial Assistance program, call 1-855-493-2500 or email financialadvocates@ahn.org. The Financial Assistance Application can be downloaded and submitted with proof of income for eligibility determination.
What insurance does Allegheny General Hospital accept?
Allegheny General Hospital, part of the Allegheny Health Network (AHN), accepts a wide range of insurance plans including Aetna, Anthem, Cigna, Humana, UnitedHealthcare, and many others. AHN has a close relationship with Highmark Blue Cross Blue Shield, serving Western and Northeastern Pennsylvania, with most Highmark plans accepted at AHN facilities within the state. However, UPMC plans may not be fully accepted at all AHN hospitals, with UPMC for Life Medicare Advantage members having full in-network access to AHN primary care physicians, specialists, and hospitals.
What awards or recognition has Allegheny General Hospital received?
Allegheny General Hospital, located in Pittsburgh, Pennsylvania, is distinguished by its Magnet recognition from the American Nurses Credentialing Center for nursing excellence. It is also recognized as a Mitral Valve Repair Reference Center by the American Heart Association and the Mitral Foundation, showcasing its expertise in cardiovascular care.